237
Views
2
CrossRef citations to date
0
Altmetric
Review

Personalized fracture risk assessment: where are we at?

Pages 191-200 | Received 07 Apr 2021, Accepted 26 Apr 2021, Published online: 13 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Piet Geusens, Natasha Appelman-Dijkstra, Willem Lems & Joop van den Bergh. (2023) Romosozumab for the treatment of postmenopausal women at high risk of fracture. Expert Opinion on Biological Therapy 23:1, pages 11-19.
Read now

Articles from other publishers (1)

Bente L. Langdahl, André G. Uitterlinden & Stuart H. Ralston. (2022) Where is bone science taking us?. Best Practice & Research Clinical Rheumatology 36:3, pages 101791.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.